After seeing the breakthrough work of scientists and clinicians during the Covid pandemic, it is exciting to work with pharma services companies as they help their clients address other diseases and illnesses and help make treatments widely available for those who might need them.
Exciting scientific advances have resulted in a new generation of treatments and therapies that in many cases improve or save the lives of patients facing a broad range of health challenges. At the same time, the pharmaceutical value chain has grown increasingly complex. Companies involved in the critical mission of scientific discovery require partners who can help them bring new products to market.
We seek to partner with companies across the entire value chain—supporting R&D, drug discovery, manufacturing, bioprocessing, packaging & logistics, clinical support, commercialization and distribution—to help the pharmaceutical sector deliver lifesaving treatments that result in improved patient outcomes.
THL’s Josh Nelson speaks with Axios on the Pharma Services Dealmaking Landscape
THL’s Megan Preiner on the Growing Trend of Outsourcing in Pharma Services and THL’s approach to building strong platforms in…
THL’s Megan Preiner talks investing in a crowded healthcare market | PE Hub
Syneos Health Announces Secondary Offering of Common Stock
Megan Preiner Managing Director
As we watch the incredible pace of innovation within the pharmaceutical industry, we’re excited to partner with the companies that are enabling these pharma companies across the value spectrum and helping bring medicines and therapies to the public as quickly and efficiently as possible.
Learn more about Medtech Services
Boosting the go-to-market strategy and accelerating new product development for a pharma services leader
Want to learn more?
Let’s explore how we can collaborate with your company.Contact